1. Home
  2. SERA

as of 11-28-2025 9:31am EST

$3.40
+$0.08
+2.41%
Stocks Health Care Precision Instruments Nasdaq

Sera Prognostics Inc is a health diagnostic company. It develops diagnostic tests for the early prediction of a woman's individualized risk of premature birth, preeclampsia, gestational diabetes, stillbirth, and other conditions. The proprietary proteomics and bioinformatics platform of the company helps to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. The Company operates as one operating segment, which is developing and commercializing its medical diagnostic products and services.

Chart Type:
Time Range:
Founded: 2008 Country:
United States
United States
Employees: N/A City: SALT LAKE CITY
Market Cap: 90.6M IPO Year: 2021
Target Price: N/A AVG Volume (30 days): 34.9K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -0.75 EPS Growth: N/A
52 Week Low/High: $1.37 - $9.13 Next Earning Date: 11-13-2025
Revenue: $95,000 Revenue Growth: 1.06%
Revenue Growth (this year): 217.92% Revenue Growth (next year): 479.25%

AI-Powered SERA Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated a day ago

AI Recommendation

hold
Model Accuracy: 76.71%
76.71%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Stock Insider Trading Activity of Sera Prognostics Inc. (SERA)

Boniface John J.

Chief Scientific Officer

Sell
SERA Nov 10, 2025

Avg Cost/Share

$2.62

Shares

7,767

Total Value

$20,349.54

Owned After

151,726

SEC Form 4

Lindgardt Zhenya

Chief Executive Officer

Sell
SERA Nov 10, 2025

Avg Cost/Share

$2.62

Shares

11,594

Total Value

$30,376.28

Owned After

796,296

SEC Form 4

Kearney Paul

Chief Data Officer

Sell
SERA Nov 10, 2025

Avg Cost/Share

$2.62

Shares

7,073

Total Value

$18,531.26

Owned After

168,596

SEC Form 4

Jackson Benjamin

General Counsel

Sell
SERA Nov 10, 2025

Avg Cost/Share

$2.62

Shares

7,059

Total Value

$18,494.58

Owned After

119,758

SEC Form 4

Aerts Austin

Chief Financial Officer

Sell
SERA Nov 10, 2025

Avg Cost/Share

$2.62

Shares

6,351

Total Value

$16,639.62

Owned After

278,319

SEC Form 4

Harrison Robert Gardner

Chief Information Officer

Sell
SERA Nov 10, 2025

Avg Cost/Share

$2.62

Shares

6,528

Total Value

$17,103.36

Owned After

89,404

SEC Form 4

Sell
SERA Nov 5, 2025

Avg Cost/Share

$3.04

Shares

221

Total Value

$671.84

Owned After

58,032

SEC Form 4

Harrison Robert Gardner

Chief Information Officer

Sell
SERA Nov 4, 2025

Avg Cost/Share

$3.07

Shares

2,000

Total Value

$6,140.00

Owned After

89,404

SEC Form 4

Harrison Robert Gardner

Chief Information Officer

Sell
SERA Oct 7, 2025

Avg Cost/Share

$3.18

Shares

2,000

Total Value

$6,360.00

Owned After

89,404

SEC Form 4

Sell
SERA Oct 6, 2025

Avg Cost/Share

$3.16

Shares

227

Total Value

$717.32

Owned After

58,032

SEC Form 4

Latest Sera Prognostics Inc. News

SERA Breaking Stock News: Dive into SERA Ticker-Specific Updates for Smart Investing

All SERA News

Share on Social Networks: